{"nct_id":"NCT02643550","title":"Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck","status":"COMPLETED","status_verified_date":"2023-05","start_date":"2015-12","start_date_type":null,"primary_completion_date":"2023-03-28","primary_completion_date_type":"ACTUAL","completion_date":"2023-03-28","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["IPHA"]}